(Q42819897)

8 November 2017

Induced pluripotent stem cells from CINCA syndrome patients as a model for dissecting somatic mosaicism and drug discovery (English)

1 reference

8 November 2017

0 references

1 reference

1 reference

9

1 reference

8 November 2017

20

Shinya Yamanaka

1 reference

8 November 2017

2

Kazutoshi Takahashi

1 reference

8 November 2017

19

Toshio Heike

1 reference

8 November 2017

Takayuki Tanaka

1

1 reference

8 November 2017

Mayu Yamane

3

1 reference

8 November 2017

Shota Tomida

4

1 reference

8 November 2017

Saori Nakamura

5

1 reference

8 November 2017

Koichi Oshima

6

1 reference

8 November 2017

Akira Niwa

7

1 reference

8 November 2017

Ryuta Nishikomori

8

1 reference

8 November 2017

Hideki Hara

10

1 reference

8 November 2017

Masao Mitsuyama

11

1 reference

8 November 2017

Nobuhiro Morone

12

1 reference

8 November 2017

John E Heuser

13

1 reference

8 November 2017

Takuya Yamamoto

14

1 reference

8 November 2017

Akira Watanabe

15

1 reference

8 November 2017

Aiko Sato-Otsubo

16

1 reference

8 November 2017

Seishi Ogawa

17

1 reference

8 November 2017

Isao Asaka

18

1 reference

8 November 2017

Tatsutoshi Nakahata

21

1 reference

8 November 2017

Megumu K Saito

22

1 reference

8 November 2017

language of work or name

English

0 references

publication date

21 June 2012

1 reference

8 November 2017

1 reference

8 November 2017

120

1 reference

8 November 2017

1299-1308

1 reference

8 November 2017

6

1 reference

describes a project that uses

8 November 2017

0 references

0 references

0 references

0 references

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1016/J.CELL.2007.11.019

Somatic coding mutations in human induced pluripotent stem cells

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/NATURE09805

Spontaneous in vivo reversion of an inherited mutation in the Wiskott-Aldrich syndrome

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2012-03-417881

Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2012-03-417881

Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2012-03-417881

Somatic mosaicism of CIAS1 in a patient with chronic infantile neurologic, cutaneous, articular syndrome.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2012-03-417881

Generation of lymphohematopoietic cells from embryonic stem cells in culture

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2012-03-417881

Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2012-03-417881

The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2012-03-417881

Isolation of MECP2-null Rett Syndrome patient hiPS cells and isogenic controls through X-chromosome inactivation

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2012-03-417881

X-linked ectodermal dysplasia and immunodeficiency caused by reversion mosaicism of NEMO reveals a critical role for NEMO in human T-cell development and/or survival

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2012-03-417881

Overcoming reprogramming resistance of Fanconi anemia cells

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2012-03-417881

Efficient and accurate homologous recombination in hESCs and hiPSCs using helper-dependent adenoviral vectors

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2012-03-417881

De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2012-03-417881

Disease-associated CIAS1 mutations induce monocyte death, revealing low-level mosaicism in mutation-negative cryopyrin-associated periodic syndrome patients

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2012-03-417881

Neuronal maturation defect in induced pluripotent stem cells from patients with Rett syndrome

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2012-03-417881

Mechanisms and consequences of somatic mosaicism in humans

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2012-03-417881

High incidence of NLRP3 somatic mosaicism in patients with chronic infantile neurologic, cutaneous, articular syndrome: results of an International Multicenter Collaborative Study

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2012-03-417881

Mosaicism of NK cells in a patient with Wiskott-Aldrich syndrome

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2012-03-417881

Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2012-03-417881

Disease-associated mutations in CIAS1 induce cathepsin B-dependent rapid cell death of human THP-1 monocytic cells

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2012-03-417881

Microbial pathogen-induced necrotic cell death mediated by the inflammasome components CIAS1/cryopyrin/NLRP3 and ASC.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2012-03-417881

Anti-inflammatory compounds parthenolide and Bay 11-7082 are direct inhibitors of the inflammasome

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2012-03-417881

Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2012-03-417881

Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*)

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2012-03-417881

Somatic gene mutation and human disease other than cancer: an update

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2012-03-417881

Pattern of interleukin-1beta secretion in response to lipopolysaccharide and ATP before and after interleukin-1 blockade in patients with CIAS1 mutations

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2012-03-417881

Long-term efficacy of the interleukin-1 receptor antagonist anakinra in ten patients with neonatal-onset multisystem inflammatory disease/chronic infantile neurologic, cutaneous, articular syndrome

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2012-03-417881

The NALP3 inflammasome is involved in the innate immune response to amyloid-beta

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2012-03-417881

Unexpected X chromosome skewing during culture and reprogramming of human somatic cells can be alleviated by exogenous telomerase

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2012-03-417881

Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2012-03-417881

KCNH2-K897T is a genetic modifier of latent congenital long-QT syndrome

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2012-03-417881

NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2012-03-417881

Gout-associated uric acid crystals activate the NALP3 inflammasome

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2012-03-417881

Oxidized ATP (oATP) attenuates proinflammatory signaling via P2 receptor‐independent mechanisms

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2012-03-417881

Cryopyrin activates the inflammasome in response to toxins and ATP

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2012-03-417881

Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2012-03-417881

Induced pluripotent stem cells--opportunities for disease modelling and drug discovery

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2012-03-417881

Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2012-03-417881

Identifiers

DOI

10.1182/BLOOD-2012-03-417881

1 reference

8 November 2017

1 reference